Ireland's Eastern Region launches cardiovascular action plan:
This article was originally published in Clinica
Executive Summary
Ireland's Eastern Regional Health Authority yesterday (October 22 2003) launched its Heart Health Action Plan. The initiative, part of the national Cardiovascular Health Strategy, is backed by funding totalling E11.75m ($13.9m) over the first four years. The plan aims to improve access to "increasingly effective treatments" to reduce heart disease mortality and morbidity. Cardiovascular disease remains the most common cause of death in the region and in Ireland as a whole, with rates that are "considerably higher than the EU average", according to the health ministry.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.